StoneX Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,234
Closed -$3.57K 990
2025
Q1
$3.57K Buy
+13,234
New +$3.57K ﹤0.01% 836